Literature DB >> 1316709

Natural course of acute and chronic monophasic inflammatory demyelinating polyneuropathies (IDP). A retrospective analysis of 266 cases.

E Gibbels1, U Giebisch.   

Abstract

The present study analyses one of the largest IDP series published as yet: 266 cases, hospitalised between 1950 and 1983, conventionally treated and uniformly supervised. There was GBS in 84%, chronic IDP in 13%, polyneuritis cranialis in 1.5%, Miller Fisher and predominantly sensory neuropathy in 0.8% each. Numerous features including preceding events, course and outcome have been investigated. Latencies between onset and maximal deficit lacked (expected) bimodality. Sensory involvement was severe, mortality (18%) and maximal disability (20% requiring ventilation) high, autonomic dysfunction (71%) prominent. Statistical comparison of various features confirmed old age, rapid onset and need for ventilation as unfavorable predicting factors. However, preceding infection, bulbar paralysis and onset of paresis in proximal muscles evolved as unfavorable prognostic features as well.

Entities:  

Mesh:

Year:  1992        PMID: 1316709     DOI: 10.1111/j.1600-0404.1992.tb04045.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

1.  Epidemiology of peripheral neuropathy.

Authors:  C N Martyn; R A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

2.  Guillain-Barré syndrome: rehabilitation outcome and recent developments.

Authors:  E M Melillo; J M Sethi; V Mohsenin
Journal:  Yale J Biol Med       Date:  1998 Sep-Oct

3.  Pure sensory Guillain-Barré syndrome: A case report and review of the literature.

Authors:  Jingjing Yang; Mingming Huan; Huajun Jiang; Chunli Song; Lin Zhong; Zhanhua Liang
Journal:  Exp Ther Med       Date:  2014-09-11       Impact factor: 2.447

Review 4.  Epidemiology of Peripheral Neuropathy: An Indian Perspective.

Authors:  Sweety Trivedi; Alak Pandit; Goutam Ganguly; Shyamal Kumar Das
Journal:  Ann Indian Acad Neurol       Date:  2017 Jul-Sep       Impact factor: 1.383

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.